Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

Phillip Anson Low, Sid Gilman

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)4-5
Number of pages2
JournalAnnals of Neurology
Volume72
Issue number1
DOIs
StatePublished - Jul 2012

Fingerprint

Mesenchymal Stem Cell Transplantation
Multiple System Atrophy
Autologous Transplantation
Mesenchymal Stromal Cells

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

@article{a799410b095d46018c7a2798fecf47ec,
title = "Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?",
author = "Low, {Phillip Anson} and Sid Gilman",
year = "2012",
month = "7",
doi = "10.1002/ana.23655",
language = "English (US)",
volume = "72",
pages = "4--5",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "1",

}

TY - JOUR

T1 - Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?

AU - Low, Phillip Anson

AU - Gilman, Sid

PY - 2012/7

Y1 - 2012/7

UR - http://www.scopus.com/inward/record.url?scp=84864444679&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864444679&partnerID=8YFLogxK

U2 - 10.1002/ana.23655

DO - 10.1002/ana.23655

M3 - Article

C2 - 22829263

AN - SCOPUS:84864444679

VL - 72

SP - 4

EP - 5

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 1

ER -